Ottawa, June 22, 2023 (GLOBE NEWSWIRE) -- According to Precedence Research, the gene synthesis market size will reach at USD 7.29 billion in 2028. The rapidly developing gene therapies with developed technologies which are utilised in the medical sectors with enhance demands from the health sector with developed infrastructures with improved facilities in the medical sector with increased gene therapies involved for treating the chronic disorders. Enhance number of chronic disorders among the population and developed new therapies with enhance efficiency of the products developed help to accelerate the market of gene synthesis.
Ask here for sample pages of report@ https://www.precedenceresearch.com/sample/2278
Increased government support with increased investment for new developments in gene synthesis and increased number of policies such as reimbruisement help to grow the market rate. Increased attraction of the customer with developed therapies and increase the market value.
Regional Snapshots
The geographical sector of North America emerged to be the developed region with highest market share with developed gene therapies in the region with increased number of gene synthesis carried out in the laboratory biologically synthesized genes with increased research and developments with new innovative techniques developed in the gene synthesis. Increased utilization of gene therapy in various chronic disorders with increasing prevalence of disorder among the population with changing lifestyle and dietary intake. Increased government support for improving the genes and increased providence for new introductions of the genes for increased number of policies help to grow the market of gene synthesis during the forecast period.
Asia Pacific region to be second highest region with enhance developments in the market with increasing disorders and increased market players encourage to grow the market of gene synthesis during the forecast period.
Report highlights
- Based on method, solid phase synthesis with increased dominance of the gene synthesis with largest market share in development of genes which are biologically synthesized and enhance utilization. PCR and chip method with highest market with increased CAGR rate of gene synthesis helps to propel the market growth. The solid-phase synthesis segment has generated revenue share of over 37% in 2021.
- Based on services, antibody DNA synthesis to hold the largest market share 37% enhance number of market players in the region with new developments with increased antibody synthesis from the companies to expand the market growth.
- Based on applications, the gene & cell therapy development segment has accounted 36% revenue share in 2021. The gene cell therapy with increased market rate of the gene synthesis with advance developed features for treating the chronic disorder with improved therapies developed and increased efficiency of the therapy help to rise the value of gene synthesis.
- Based on end user, academic institution and government with enhance investment from the various regions to increase research and development helps to expand the market of gene synthesis with the increased CAGR of the market which helps to boost the market with continuous research and development and enhance market rate of gene synthesis.
- Based on geography, the North America to be highest region with increased new developments and increased chronic disorders among the population propels the market growth. Asia Pacific region with second highest position with new developments in gene synthesis with increased demands from the customers. Europe, Latin America, Middle East and Africa to expand the market growth of gene synthesis.
Recent developments
- July 2022, OmniGene the Gut DNA and DNA product (OMR-205) launched by teh OraSure Technologies.
- April 2022, DNA script lunched in the early program with new technologies developed in the synthesis for syntax system customer with latest developments.
You can further customize the report@ https://www.precedenceresearch.com/customization/2278
Scope of this report
| Coverage | Details |
| Market Size in 2028 | USD 7.29 Billion |
| CAGR | 19.45% from 2022 to 2030 |
| North America Revenue Share | 39% in 2021 |
| Antibody DNA Synthesis Segment Share | 61% in 2021 |
| Key Players | OriGene Technologies,Inc, Integrated DNA Technologies, Inc, Thermo Fisher Scientific, Inc, ProMab Biotechnologies, Inc, Eurofins Scientific, Biomatik, ProteoGenix, Bosyer Biological Technology, GenScript, Brooks Automation, Inc (GENEWIZ), Twist Bioscience, Codex DNA |
Market Dynamics
Drivers
The widely developing new gene therapies involved in treating the disorders with increased huge number of gene synthesis developed from synthetic biology known as artificial genes with increased requirement from the medical sector with increasing number of chronic disorders among the population such as cancer, respiratory disorders, HIV, AIDS, and many more disorders with enhance demands to treat the disease with increased efficiency of the treatment, long lasting therapy helps to expand the market of gene synthesis. Increased research and development in gene synthesis with new launches introduced by key market players in gene therapy with increased efficacy of the treatment helps to boost the market of gene synthesis during the forecast period.
Restraints
Lack of awareness among the people regarding the treatment of gene therapy and enhance benefits of the therapy with developed technologies in the market may hamper the market of gene synthesis and may reduce the market share during the forecast period. Number of policies available in the health care sector introduced by the government or various companies with enhance benefits from the policies may hamper the market of gene synthesis with reduced utilization in the medical sector. Huge number of availabilities of treatment for prevention of the chronic disorders other than gene therapy may reduce the market value of gene synthesis.
Opportunities
Enhance underdeveloped regions with increasing developments across the regions with increased demands from the market with increased facilities and enhance performance from the gene therapy with good output with developed techniques in the gene therapy helps to grow the market of gene synthesis. Increasing number of chronic disorders with rapid advance and increased acceptance from the medical sector with enhance results and increased prevention of various disorders helps to boost the market of gene synthesis. Enhance support from the government for new developments and increased funding may accelerate the market to grow. Research and development in gene synthesis for new developments may propel the market rate during the forecast period.
Challenges
The developed technologies with increased efficiency of the gene therapy for prevention of the diseases led to enhance cost of the therapy which can challenge the market of gene synthesis to grow due to reduced demands from the customers due to increased cost of the therapy. Increased skill for carrying out the procedure with new innovative developed technologies. Lack of skill among the people to perform the procedure involved in treatment may reduce the market size of the gene synthesis during the forecast period. Availability of number of treatments available to treat the disorder may decline the market revenue of gene synthesis.
Related Reports
- Cancer Gene Therapy Market - The global cancer gene therapy market size was valued at USD 2.37 billion in 2022 and is expanding around USD 15.2 billion by 2032 with a CAGR of 20.42% from 2023 to 2032.
- Cell and Gene Therapy Market - The global cell and gene therapy market size was valued at USD 18.61 billion in 2022 and is expanding around USD 93.78 billion by 2030 with a CAGR of 22.41% from 2022 to 2030.
Market Segmentation
By Method
- Solid-phase synthesis
- Chip-based synthesis
- PCR- based Enzyme synthesis
By Service
- Antibody DNA synthesis
- Viral DNA synthesis
- Others
By Application
- Gene & cell therapy development
- Vaccine development
- Diseases diagnosis
- Others
By End Users
- Biotechnology & pharmaceutical companies
- Academic & government research institutes
- Contract research organizations
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/2278
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333
About Us
Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
For Latest Update Follow Us:
https://www.linkedin.com/company/precedence-research/
https://www.facebook.com/precedenceresearch/
https://twitter.com/Precedence_R
